January 22, 2021
Although prostate cancer is one the most common types of malignancy in men, diagnosis is typically made on the basis of the Prostate-specific antigen (PSA), with an accuracy as low as 30%. Given how unreliable PSA-based testing can often be, many patients require invasive biopsy which often leaves them with […]
